Hypha Labs Shares Outstanding History (FUNI)
Hypha Labs reported 147.1M shares outstanding at the end of fiscal 2025.
View full Hypha Labs company overviewHypha Labs annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 147.1M | 24.1M | +19.57% |
| 2024 | 2024-09-30 | 123.0M | 36.0M | +41.28% |
| 2023 | 2023-09-30 | 87.1M | 11.9M | +15.90% |
| 2022 | 2022-09-30 | 75.1M | 3.9M | +5.50% |
| 2021 | 2021-09-30 | 71.2M | 13.0M | +22.24% |
| 2020 | 2020-09-30 | 58.3M | 9.9M | +20.49% |
| 2019 | 2019-09-30 | 48.4M | 6.1M | +14.48% |
| 2018 | 2018-09-30 | 42.2M | 7.2M | +20.61% |
| 2017 | 2017-09-30 | 35.0M | 12.5M | +55.74% |
| 2016 | 2016-09-30 | 22.5M | 8.7M | +63.42% |
| 2015 | 2015-09-30 | 13.8M | 7.9M | +134.23% |
| 2014 | 2014-09-30 | 5.9M | 5.3M | +961.27% |
| 2013 | 2013-09-30 | 553,640 | — | — |
Hypha Labs quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 163.9M | 18.8M | +12.94% |
| Q2 2026 | 2026-03-31 | 163.9M | 27.3M | +19.96% |
| Q1 2026 | 2025-12-31 | 155.5M | 29.0M | +22.90% |
| Q4 2025 | 2025-09-30 | 147.1M | 24.1M | +19.57% |
| Q3 2025 | 2025-06-30 | 145.1M | 32.4M | +28.75% |
| Q2 2025 | 2025-03-31 | 136.6M | 31.3M | +29.77% |
| Q1 2025 | 2024-12-31 | 126.5M | 39.5M | +45.29% |
| Q4 2024 | 2024-09-30 | 123.0M | 36.0M | +41.28% |
| Q3 2024 | 2024-06-30 | 112.7M | 25.6M | +29.41% |
| Q2 2024 | 2024-03-31 | 105.3M | 23.0M | +27.93% |
| Q1 2024 | 2023-12-31 | 87.1M | 4.8M | +5.83% |
| Q4 2023 | 2023-09-30 | 87.1M | 11.9M | +15.90% |
| Q3 2023 | 2023-06-30 | 87.1M | 11.9M | +15.90% |
| Q2 2023 | 2023-03-31 | 82.3M | 7.2M | +9.51% |
| Q1 2023 | 2022-12-31 | 82.3M | 9.6M | +13.15% |
| Q4 2022 | 2022-09-30 | 75.1M | 3.9M | +5.50% |
| Q3 2022 | 2022-06-30 | 75.1M | 5.4M | +7.77% |
| Q2 2022 | 2022-03-31 | 75.1M | 7.0M | +10.22% |
| Q1 2022 | 2021-12-31 | 72.7M | 8.7M | +13.52% |
| Q4 2021 | 2021-09-30 | 71.2M | 13.0M | +22.24% |
| Q3 2021 | 2021-06-30 | 69.7M | 12.1M | +21.03% |
| Q2 2021 | 2021-03-31 | 68.2M | 10.6M | +18.35% |
| Q1 2021 | 2020-12-31 | 64.1M | 7.3M | +12.92% |
| Q4 2020 | 2020-09-30 | 58.3M | 9.7M | +20.06% |
| As of Aug 14, 2020 | 2020-08-14 | 57.6M | 9.3M | +19.13% |
| Q3 2020 | 2020-06-30 | 57.6M | 9.5M | +19.64% |
| Q2 2020 | 2020-03-31 | 56.7M | 9.1M | +19.17% |
| Q1 2020 | 2019-12-31 | 48.5M | 4.8M | +10.91% |
| Q4 2019 | 2019-09-30 | 48.4M | 6.1M | +14.48% |
| Q3 2019 | 2019-06-30 | 48.2M | 7.3M | +17.75% |
| Q2 2019 | 2019-03-31 | 47.6M | 7.9M | +19.81% |
| Q1 2019 | 2018-12-31 | 43.8M | 6.5M | +17.36% |
| Q4 2018 | 2018-09-30 | 42.2M | 7.2M | +20.61% |
| Q3 2018 | 2018-06-30 | 40.9M | 8.9M | +27.64% |
| Q2 2018 | 2018-03-31 | 39.7M | 9.0M | +29.21% |
| Q1 2018 | 2017-12-31 | 37.3M | 12.3M | +49.20% |
| Q4 2017 | 2017-09-30 | 35.0M | 12.5M | +55.74% |
| Q3 2017 | 2017-06-30 | 32.0M | 11.1M | +52.68% |
| Q2 2017 | 2017-03-31 | 30.8M | 12.2M | +65.77% |
| Q1 2017 | 2016-12-31 | 25.0M | 9.9M | +65.18% |
| Q4 2016 | 2016-09-30 | 22.5M | 8.7M | +63.42% |
| Q3 2016 | 2016-06-30 | 21.0M | 8.9M | +72.92% |
| Q2 2016 | 2016-03-31 | 18.6M | 9.0M | +93.79% |
| Q1 2016 | 2015-12-31 | 15.1M | 6.9M | +82.81% |
| Q4 2015 | 2015-09-30 | 13.8M | 7.9M | +134.23% |
| Q3 2015 | 2015-06-30 | 12.1M | 11.6M | +2092.03% |
| Q2 2015 | 2015-03-31 | 9.6M | — | — |
| Q1 2015 | 2014-12-31 | 8.3M | — | — |
| Q4 2014 | 2014-09-30 | 5.9M | — | — |
| Q4 2013 | 2013-09-30 | 553,640 | — | — |
Hypha Labs shares outstanding trends
Over the last five reported fiscal years, Hypha Labs's shares outstanding moved from 58.3M to 147.1M, a change of 88.9M. The latest reported quarter, Q3 2026, shows 163.9M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Hypha Labs filings at SEC.gov ↗